Extina

Histoplasmosis, Paracoccidioidomycosis, Chromoblastomycosis + 22 more

Treatment

4 Active Studies for Extina

What is Extina

Ketoconazole

The Generic name of this drug

Treatment Summary

Ketoconazole is an antifungal drug approved by the FDA in 1981 to treat fungal infections. It works by blocking the synthesis of a type of cholesterol found in fungi, which prevents the fungi from growing. While it was originally considered a good drug for treating fungal infections, it had frequent side effects in the stomach and liver, so newer drugs like fluconazole, itraconazole, voriconazole, and posaconazole were developed to replace it. Despite this, ketoconazole is still used in topical formulations.

Nizoral

is the brand name

image of different drug pills on a surface

Extina Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Nizoral

Ketoconazole

1981

135

Effectiveness

How Extina Affects Patients

Ketoconazole is an antifungal medicine that works by stopping the growth and spread of fungi in the body. It is a type of medicine called an azole antifungal and has been shown to be effective at preventing fungus from growing and spreading.

How Extina works in the body

Ketoconazole stops fungi cells from making a special type of cholesterol called ergosterol. This stops the cells from functioning properly and makes them more permeable. As a result, the cells become less tightly packed, which stops the cells from working correctly. The drug also produces a toxic by-product that further inhibits the cell's activity.

When to interrupt dosage

The prescribed dose of Extina is contingent upon the diagnosed condition, for example Vulvovaginal Candidiasis, Cushing Syndrome and Chromomycosis. The amount of dosage is reliant on the technique of delivery (e.g. Cream or Aerosol, foam - Topical) featured in the table below.

Condition

Dosage

Administration

Histoplasmosis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Paracoccidioidomycosis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Chromoblastomycosis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Blastomycosis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Coccidioidomycosis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Dandruff

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

cutaneous candidiasis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Candidiasis, Vulvovaginal

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Candidiasis, Chronic Mucocutaneous

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Dermatitis, Seborrheic

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Candidiasis, Vulvovaginal

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Cushing Syndrome

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Bacterial Vaginosis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Trichophyton mentagrophytes

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Tinea cruris

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Tinea Pedis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Tinea Pedis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Tinea corporis (disorder)

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Tinea Pedis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

recalcitrant Dermatophytosis

, 0.02 mg/mg, 200.0 mg, 10.0 mg/mL, 20.0 mg, 20.0 mg/mL, 2.0 %, 20.5 mg/mL

, Topical, Cream, Cream - Topical, Oral, Tablet, Tablet - Oral, Gel, Gel - Topical, Aerosol, foam, Aerosol, foam - Topical, Kit, Shampoo, Shampoo - Topical, Shampoo, suspension, Shampoo, suspension - Topical, Suspension - Oral, Suspension, Kit - Topical

Warnings

Extina has forty-three contraindications and should not be administered if the individual is affected by any of the conditions in the table below.

Extina Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Liver Dysfunction

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Long QT Syndrome

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Long QT Syndrome

Do Not Combine

Renal Insufficiency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Ketoconazole may interact with Pulse Frequency

There are 20 known major drug interactions with Extina.

Common Extina Drug Interactions

Drug Name

Risk Level

Description

(R)-warfarin

Major

The metabolism of (R)-warfarin can be decreased when combined with Ketoconazole.

(S)-Warfarin

Major

The metabolism of (S)-Warfarin can be decreased when combined with Ketoconazole.

1,2-Benzodiazepine

Major

The metabolism of 1,2-Benzodiazepine can be decreased when combined with Ketoconazole.

3,5-diiodothyropropionic acid

Major

The metabolism of 3,5-diiodothyropropionic acid can be decreased when combined with Ketoconazole.

5-androstenedione

Major

The metabolism of 5-androstenedione can be decreased when combined with Ketoconazole.

Extina Toxicity & Overdose Risk

An overdose of ketoconazole can cause liver problems, such as appetite loss, tiredness, nausea, and yellowing of the skin. Within an hour of taking ketoconazole, doctors may administer activated charcoal to reduce the effects. If a patient shows signs of adrenal insufficiency, they should be given 100mg of hydrocortisone, as well as saline and glucose solution. Blood pressure and electrolyte levels should be monitored in the following days.

image of a doctor in a lab doing drug, clinical research

Extina Novel Uses: Which Conditions Have a Clinical Trial Featuring Extina?

A total of 6 active trials are currently exploring the potential of Extina to treat Trichophyton mentagrophytes, Vaginal Candidiasis and Vulvovaginal Candidiasis.

Condition

Clinical Trials

Trial Phases

Coccidioidomycosis

0 Actively Recruiting

Chromoblastomycosis

0 Actively Recruiting

Paracoccidioidomycosis

0 Actively Recruiting

Tinea corporis (disorder)

0 Actively Recruiting

Tinea corporis (disorder)

0 Actively Recruiting

Blastomycosis

0 Actively Recruiting

Candidiasis, Chronic Mucocutaneous

0 Actively Recruiting

Tinea Pedis

0 Actively Recruiting

Malassezia

0 Actively Recruiting

Candidiasis, Vulvovaginal

2 Actively Recruiting

Not Applicable, Phase 3

recalcitrant Dermatophytosis

0 Actively Recruiting

Candidiasis, Systemic

0 Actively Recruiting

Cushing Syndrome

0 Actively Recruiting

Trichophyton mentagrophytes

0 Actively Recruiting

Tinea cruris

0 Actively Recruiting

Tinea Corporis caused by Trichophyton mentagrophytes

0 Actively Recruiting

Trichophyton rubrum

0 Actively Recruiting

cutaneous candidiasis

0 Actively Recruiting

Candidiasis, Vulvovaginal

0 Actively Recruiting

Bacterial Vaginosis

2 Actively Recruiting

Phase 2, Early Phase 1

Extina Reviews: What are patients saying about Extina?

5

Patient Review

7/28/2011

Extina for Scaly Oily Skin Problem Primarily On Face and Scalp

This has been an absolute godsend for my seborrheic dermatitis. Within just a few uses, the foam has cleared up my flares. I haven't experienced any real drying or extra flaking, which is great. I'm using it about once every two days, and so far so good. Overall, I absolutely love this medication!

5

Patient Review

5/9/2017

Extina for Scaly Oily Skin Problem Primarily On Face and Scalp

After just two days, I noticed drastic differences. This cleared up problem areas without any observed side effects. Even when using it only occasionally for maintenance (not daily), the benefits remain.

4

Patient Review

12/16/2008

Extina for Scaly Oily Skin Problem Primarily On Face and Scalp

This effectively removed the flakes on my scalp after just two uses. You have to keep using it to maintain the results, but it's worth it to me.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about extina

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is extina used for?

"This medication is used to treat seborrheic dermatitis. Seborrheic dermatitis is a skin condition caused by a fungus called Malassezia furfur. Symptoms of seborrheic dermatitis include dry, flaky skin (scaling) on the scalp, face, ears, chest, or upper back."

Answered by AI

What is ketoconazole mainly used for?

"Ketoconazole is used to treat infections caused by fungi or yeast. By killing the fungus or yeast, or preventing its growth, the Ketoconazole cream can treat: Athlete's foot (tinea pedis; ringworm of the foot); Feb 1, 2022."

Answered by AI

Is extina a prescription drug?

"Extina is a prescription medicine that can be used to treat the symptoms of various conditions, including Seborrheic Dermatitis, Dandruff (Seborrhea), Tinea Versicolor, Tinea Corporis (Ringworm), Tinea Cruris (Jock Itch), and Tinea Pedis (Athlete's Foot)."

Answered by AI

What is mycelex cream used for?

"This medication is used to treat vaginal yeast infections. Clotrimazole reduces vaginal burning, itching, and discharge that may occur with this condition by stopping the growth of yeast (fungus) that causes the infection."

Answered by AI

Clinical Trials for Extina

Image of University of Minnesota in Minneapolis, United States.

LAmB and Posaconazole for Histoplasmosis

18+
All Sexes
Minneapolis, MN

The purpose of the study is threefold: 1. Assess the safety and efficacy of a single high-dose intravenous (LAmB 10mg/kg) compared to the SOC daily dosing (3mg/kg) of the same medication for induction therapy in moderate to severe histoplasmosis. 2. Assess the safety and efficacy of oral posaconazole 300mg delayed-release tablets three times daily for two days then once daily for consolidation therapy compared to SOC oral itraconazole 200 mg capsules three times daily for three days then twice daily in moderate to severe histoplasmosis 3. Assess the safety and efficacy of 6 months of consolidation therapy compared to the SOC 12 months of consolidation therapy in persons with HIV on appropriate antiretroviral therapy.

Phase 3
Waitlist Available

University of Minnesota

Nathan Bahr, MD

Image of Rush University Medical Center in Chicago, United States.

Menstrual Cups for Vaginal Infections

15 - 35
Female
Chicago, IL

HIV remains a global pandemic with 37 million infected. In western Kenya, 16% of women in the general population and 29% of the poorest women have HIV. The HIV and sexually transmitted infection (STI) epidemics overlap with broader reproductive health concerns. Menstrual hygiene management is a big problem in low- and middle-income countries and a lack of menstrual products negatively impacts women's work-life. This comes from cultural taboos, stigma, and discrimination, promoting secrecy around menstruation, high cost of menstrual products, use of traditional materials (e.g. rags, cotton wool, etc.) causing leakage and odor, and lack of water and safe hygiene facilities. Menstrual cups designed for use during sex may help women prevent Bacterial vaginosis (BV) and STIs through hygienic period practices, and may help them avoid bad practices in an attempt to maintain vaginal dryness. The goal of this interventional trial is to test the impact of menstrual cups on vaginal microbiome, BV, and STIs of poor women at high risk for STIs and HIV. We predict to see 25% less BV, our primary outcome, over one year. This trial aims to learn more about the safety of the intervention, and understand what is needed to fully implement the program.

Phase 2
Waitlist Available

Rush University Medical Center